Status:
NOT_YET_RECRUITING
Behavioral Intervention for Lifestyle Physical Activity in Parkinson's Disease
Lead Sponsor:
University of Illinois at Chicago
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Parkinson Disease (PD)
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The investigators propose a Stage-I randomized controlled trial (RCT) of a remotely-delivered, 16-week social-cognitive theory-based behavioral intervention focusing on combined exercise (aerobic and ...
Detailed Description
Parkinson's disease (PD) is a neurodegenerative disorder of the dopamine-producing nerve cells in the basal ganglia, and age is a primary risk factor for PD. Cognitive impairment is prevalent, disabli...
Eligibility Criteria
Inclusion
- confirmed diagnosis of PD
- Internet and email access
- willingness to complete the cognitive assessments and questionnaires, wear the accelerometer, and undergo randomization
- insufficient physical activity (i.e., not meeting current physical activity guidelines) based on a health contribution score of less than 14 units from the Godin Leisure-Time Exercise Questionnaire
- self-reported ability to ambulate without assistance
- age of 50+ years
- English as a primary language
- asymptomatic (i.e., one or fewer affirmatives on the Physical Activity Readiness Questionnaire \[PAR-Q\]) or physician approval for undertaking exercise training for those with 2 or more affirmatives on the PAR-Q
Exclusion
- above inclusion criteria not met
- moderate or high risk of contraindications for possible injury or death when undertaking strenuous or maximal exercise using the PAR-Q
- severe cognitive impairment that might preclude compliance with the conditions based on a modified Telephone Interview for Cognitive Status (TICS-M) score of less than 18
- normal cognitive impairment based on the Montreal Cognitive Assessment (MoCA) score of 26 or more for avoiding ceiling effects involving change in cognitive function
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06603012
Start Date
January 1 2026
End Date
August 1 2027
Last Update
January 6 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois at Chicago
Chicago, Illinois, United States, 60612